biostudies-literatureRosas-Ramirez DDirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México832-837https://www.ebi.ac.uk/biostudies/studies/S-EPMC7790519biostudies-literatureUnknown30(6)The ethanol/water-soluble extracts of the roots of <i>Smilax moranensis</i> M. Martens & Galeotti, Smilacaceae, which have been appreciated since pre-Hispanic times and traditionally used to treat type 2 diabetes in Mexico, were fractionated by the application of the affinity-directed method to identify glucose-6-phosphatase and α-glucosidase inhibitors. Mass spectrometry was used to identify the inhibitor as free ligands after released from the enzymatic complex by denaturing acidic conditions. The affinity study led to the identification of chlorogenic acid as a glucose-6-phosphatase inhibitor, which is the most abundant metabolite present in the analyzed crude drug. In addition, the affinity studies led to the identification of a flavonolignan glycoside as an α-glucosidase inhibitor. <iRevista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de FarmacognosiaGlucose-6-Phosphatase and α-Glucosidase Inhibitors from <i>Smilax moranensis</i> Roots Identified by Affinity-Directed Fractionation.PMC7790519IG20021IN226719Rosas-Ramirez DAndrade-Cetto AArreguin-Espinosa REscandon-Rivera SfalseGlucose-6-Phosphatase and α-Glucosidase Inhibitors from <i>Smilax moranensis</i> Roots Identified by Affinity-Directed Fractionation.The ethanol/water-soluble extracts of the roots of <i>Smilax moranensis</i> M. Martens & Galeotti, Smilacaceae, which have been appreciated since pre-Hispanic times and traditionally used to treat type 2 diabetes in Mexico, were fractionated by the application of the affinity-directed method to identify glucose-6-phosphatase and α-glucosidase inhibitors. Mass spectrometry was used to identify the inhibitor as free ligands after released from the enzymatic complex by denaturing acidic conditions. The affinity study led to the identification of chlorogenic acid as a glucose-6-phosphatase inhibitor, which is the most abundant metabolite present in the analyzed crude drug. In addition, the affinity studies led to the identification of a flavonolignan glycoside as an α-glucosidase inhibitor. <i2020-01-01T00:00:00Z20202025-04-06T12:19:37.039Z2021-02-20T21:36:02ZS-EPMC77905193343710510.1007/s43450-020-00116-3